Cargando…
PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest
Protein kinase-mediated phosphorylation plays a critical role in many biological processes. However, the identification of key regulatory kinases is still a great challenge. Here, we develop a trans-omics-based method, central kinase inference, to predict potentially key kinases by integrating quant...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448736/ https://www.ncbi.nlm.nih.gov/pubmed/36068222 http://dx.doi.org/10.1038/s41467-022-32976-9 |
_version_ | 1784784131659399168 |
---|---|
author | Yuan, Yangyang Wang, Chenwei Zhuang, Xuran Lin, Shaofeng Luo, Miaomiao Deng, Wankun Zhou, Jiaqi Liu, Lihui Mao, Lina Peng, Wenbo Chen, Jian Wang, Qiangsong Shu, Yilai Xue, Yu Huang, Pengyu |
author_facet | Yuan, Yangyang Wang, Chenwei Zhuang, Xuran Lin, Shaofeng Luo, Miaomiao Deng, Wankun Zhou, Jiaqi Liu, Lihui Mao, Lina Peng, Wenbo Chen, Jian Wang, Qiangsong Shu, Yilai Xue, Yu Huang, Pengyu |
author_sort | Yuan, Yangyang |
collection | PubMed |
description | Protein kinase-mediated phosphorylation plays a critical role in many biological processes. However, the identification of key regulatory kinases is still a great challenge. Here, we develop a trans-omics-based method, central kinase inference, to predict potentially key kinases by integrating quantitative transcriptomic and phosphoproteomic data. Using known kinases associated with anti-cancer drug resistance, the accuracy of our method denoted by the area under the curve is 5.2% to 29.5% higher than Kinase-Substrate Enrichment Analysis. We further use this method to analyze trans-omic data in hepatocyte maturation and hepatic reprogramming of human dermal fibroblasts, uncovering 5 kinases as regulators in the two processes. Further experiments reveal that a serine/threonine kinase, PIM1, promotes hepatic conversion and protects human dermal fibroblasts from reprogramming-induced ferroptosis and cell cycle arrest. This study not only reveals new regulatory kinases, but also provides a helpful method that might be extended to predict central kinases involved in other biological processes. |
format | Online Article Text |
id | pubmed-9448736 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-94487362022-09-08 PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest Yuan, Yangyang Wang, Chenwei Zhuang, Xuran Lin, Shaofeng Luo, Miaomiao Deng, Wankun Zhou, Jiaqi Liu, Lihui Mao, Lina Peng, Wenbo Chen, Jian Wang, Qiangsong Shu, Yilai Xue, Yu Huang, Pengyu Nat Commun Article Protein kinase-mediated phosphorylation plays a critical role in many biological processes. However, the identification of key regulatory kinases is still a great challenge. Here, we develop a trans-omics-based method, central kinase inference, to predict potentially key kinases by integrating quantitative transcriptomic and phosphoproteomic data. Using known kinases associated with anti-cancer drug resistance, the accuracy of our method denoted by the area under the curve is 5.2% to 29.5% higher than Kinase-Substrate Enrichment Analysis. We further use this method to analyze trans-omic data in hepatocyte maturation and hepatic reprogramming of human dermal fibroblasts, uncovering 5 kinases as regulators in the two processes. Further experiments reveal that a serine/threonine kinase, PIM1, promotes hepatic conversion and protects human dermal fibroblasts from reprogramming-induced ferroptosis and cell cycle arrest. This study not only reveals new regulatory kinases, but also provides a helpful method that might be extended to predict central kinases involved in other biological processes. Nature Publishing Group UK 2022-09-06 /pmc/articles/PMC9448736/ /pubmed/36068222 http://dx.doi.org/10.1038/s41467-022-32976-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Yuan, Yangyang Wang, Chenwei Zhuang, Xuran Lin, Shaofeng Luo, Miaomiao Deng, Wankun Zhou, Jiaqi Liu, Lihui Mao, Lina Peng, Wenbo Chen, Jian Wang, Qiangsong Shu, Yilai Xue, Yu Huang, Pengyu PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest |
title | PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest |
title_full | PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest |
title_fullStr | PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest |
title_full_unstemmed | PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest |
title_short | PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest |
title_sort | pim1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448736/ https://www.ncbi.nlm.nih.gov/pubmed/36068222 http://dx.doi.org/10.1038/s41467-022-32976-9 |
work_keys_str_mv | AT yuanyangyang pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest AT wangchenwei pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest AT zhuangxuran pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest AT linshaofeng pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest AT luomiaomiao pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest AT dengwankun pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest AT zhoujiaqi pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest AT liulihui pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest AT maolina pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest AT pengwenbo pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest AT chenjian pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest AT wangqiangsong pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest AT shuyilai pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest AT xueyu pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest AT huangpengyu pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest |